AN OPEN NON- RANDOMIZED PHASE II CLINICAL TRIAL TO EVALUATE THE THERAPEUTIC EFFICACY OF SIDDHA SHASTRIC MEDICINE INJI CHOORANAM - 2 [INTERNAL], VATHA KESARI THYLAM [EXTERNAL] AND VARMAM THERAPY FOR THE TREATMENT OF PAKKA VAYU [HEMIPLEGIA].

Mathan0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•2.SEX: Both male and female.
•3. Inability/ difficulty to use one side of the upper and lower limb.
•4. Difficulty in speech.
•5.Patient with Thrombotic or Embolic stroke.
•6.Willing for admission in IPD for 48 days or willing to attend OPD regularly.
•7.Patients who are willing to participate in this study with knowledge of potential risks and who are willing to sign the informed consent form.
•8.Patient who are willing to give blood sample for laboratory investigation

•1.Patient in an acute phase of CVA.
•2.Pregnant women and lactating mother.
•3.Known Hypersensitivity or allergy to trial drugs.
•4.Patients with other serious, advanced or terminal illness.
•5.Bed sores.
•6.Bladder and Bowel control lost.
•7.Epilepsy.
•8.Comatose and unconscious patients.
•9.Patient with haemorrhagic stroke, Neoplasam, subarachanoid haemorrhage, AV malformation.
•10.Dermatological issues.
•11.Congenital defects -diffuse sclerosis, cerebral agenesis etc.
•12.Post operative cases within 3 months [eg.CVD, etc.], Head injury.

发起方

Mathan